DacarbazineThird Party Manufacturing in India

Dacarbazine works by interfering with the replication of DNA in cancer cells, thereby preventing them from dividing and multiplying.

As a prodrug, dacarbazine is activated in the liver by microsomal enzymes to form highly reactive methylating intermediates. These active compounds bind to DNA and add alkyl groups to guanine bases, forming covalent DNA adducts that cross-link the DNA strands and distort the double helix structure. This disruption prevents the cells from transcribing and replicating their DNA, ultimately triggering apoptosis or programmed cell death.

Unlike cell-cycle specific chemotherapy drugs that only target cells in a particular phase, Dacarbazine is cell-cycle non-specific, allowing it to kill cancer cells throughout their growth cycle. It is highly effective for patients undergoing treatment for skin and lymphatic cancers.

Dacarbazine (CAS 4342-03-4) is a critical antineoplastic agent used widely in cancer chemotherapy. Celesta provides high-quality solutions for Dacarbazine third party manufacturing in India, supplying global markets with sterile injectable formulations.

Therapeutic Uses

Dacarbazine is prescribed for the treatment of:

• Metastatic Malignant Melanoma: Used as a first-line chemotherapy agent to treat advanced melanoma that has spread to other parts of the body.
• Hodgkin's Lymphoma: Combined with other chemotherapy agents in the standard ABVD regimen to treat patients with advanced Hodgkin's disease.
• Soft Tissue Sarcoma: Utilized in combination therapies to treat adult patients suffering from advanced sarcomas, excluding mesothelioma.

Choosing a Dacarbazine Manufacturer in India

Dacarbazine is a vital component of essential oncology care systems and is included in the WHO Model List of Essential Medicines. This clinical importance ensures a stable, high-volume demand from hospital networks, national procurement bodies, and exporting organizations. For pharmaceutical distributors, partnering with a reliable Dacarbazine manufacturer is key to entering the specialized oncology tender market. Because it is a cytotoxic drug, formulation requires dedicated high-containment suites in WHO-GMP certified facilities to ensure absolute operator safety and zero cross-contamination. Sourcing Dacarbazine injection from a WHO-GMP certified partner in India guarantees sterile, pyrogen-free vials that comply with international pharmacopoeias.

To discuss procurement, please contact our team. You can browse our complete line of oncology products on our manufacturing listing page or explore our contract manufacturing services.

This makes Dacarbazine one of the most sought-after molecules for third party manufacturing in India, with consistent demand from oncology hospitals and export-oriented companies.